ABSTRACT: Bone healing, biocompatibility, and safety employing the IlluminOss System (IS), comprised of an inflatable balloon filled with photopolymerizable liquid monomer, was evaluated in New Zealand white rabbits. Successful bone healing and callus remodeling over 6 months was demonstrated radiologically and histologically with IS implants in fenestrated femoral cortices. Biocompatibility was demonstrated with IS implants in brushed, flushed femoral intramedullary spaces, eliciting no adverse, local, or systemic responses and with similar biocompatibility to K-wires in contralateral femurs up to 1 year post-implant. Lastly simulated clinical failures demonstrated the safety of IS implants up to 1 year in the presence of liquid or polymerized polymer within the intramedullary space. Polymerized material displayed cortical bone and vasculature effects comparable to mechanical disruption of the endosteum. In the clinically unlikely scenario with no remediation or polymerization, a high dose monomer injection resulted in marked necrosis of cortical bone, as well as associated vasculature, endosteum, and bone marrow. Overall, when polymerized and hardened within bone intramedullary spaces, this light curable monomer system may provide a safe and effective method for fracture stabilization. ß
Bone fracture stabilization with splints, casts, metal fixator plates, or intramedullary (IM) rods promote fracture healing by controlling bone movement and alignment. 1 A critical balance must be attained to allow some motion to promote normal healing, but not sufficient to create instability leading to non-union. 2 Each degree of invasiveness adds to assurance of fixation, but raises complications. The extramedullary periosteal application of plates, indicated where anatomic reduction, and stabilization cannot be maintained with simpler techniques, provides greater fracture fixation immediately after reduction and earlier return to motion. However, plating and screw fixations are time consuming, require a greater amount of soft tissue dissection, and have significant complications 3 that include plate prominence which may result in pain, as well as the potential for infection and tendon adhesions, and a higher incidence of symptomatic fibrous unions or non-unions. 4, 5 Furthermore, plates are usually removed after the fracture has healed requiring additional surgery. IM rods have certain advantages over plates and screws including lower bending forces, making failure by fatigue less likely. 6 Percutaneous IM fixation may be an ideal way to stabilize proximal and distal articular extension fractures. 7 Current devices, however, are associated with various complications including delayed union, device displacement, and nerve impingement. 3, [8] [9] [10] [11] [12] [13] [14] Additionally, IM nails typically provide no rotational stability and require additional locking screws.
A new percutaneous photodynamic balloon stabilization system, IlluminOss System (IS), has been developed involving the delivery of a non-compliant polyethylene terephthalate (PET) balloon into the medullary canal (MC) spanning the fracture site, and the infusion of a photopolymerizable liquid monomer within the balloon. Through the infusion of the monomer, the balloon expands and fills the medullary canal, conforming to the unique geometry of a patient's bone. Once the light source is activated, the monomer hardens and creates a stable fixation system, 15 with a modulus of elasticity similar to that of bone. The implant provides the requisite amount of strength to stabilize the fracture, while the irregular shape of the implant within the canal provides rotational stability. Additional hardware (pins and screws) may then be used in any desired location to add further fracture stability. This new system has been used successfully to clinically stabilize fractures in lowload bearing bones, 15, 16 and prior preclinical studies in sheep have demonstrated feasibility of the IS for fracture fixation in high load-bearing tibiae. 17 Here we sought to gain a better understanding of the local and systemic biocompatibility, bone healing, and safety characteristics of monomeric and polymeric material of the IS in high load-bearing rabbit femurs.
were maintained under environmental controls consistent with the Guide for the Care and Use of Laboratory Animals and fed ad libitum commercial rabbit chow. Animals were anesthetized with ketamine (25-35 mg/kg) and medetomidine/xylazine (0.5 mg/kg or 1-5 mg/kg, respectively) and maintained on isoflurane. Cefazolin (20-30 mg/kg) was administered prior to surgery and for the subsequent 24 h. Analgesia was provided with fentanyl (0.01 mg/kg, 25 mcg/h transdermal patch) and carprofen (4 mg/kg) for 3-4 days. Treatments and evaluations are summarized in Table 1 .
Local & Systemic Biocompatibility A medial parapatellar incision was made over the anterior surface of the left or right knee and the patella and patellar tendon were retracted laterally exposing the intercondylar groove of the distal femoral condyle. Drill sites were created with an awl and a 4.0 mm hole was drilled and subsequently over-drilled with a 5 mm bit into the femoral IM canal from the intercondylar groove. The IM canal was cleaned with a stainless steel spiral brush and saline flushed. For local and systemic biocompatibility evaluations, the implant end of the IS was inserted into the prepared left femoral canal, then filled through the use of a syringe with photo-reactive monomer. Once pressurized, 436 nm wavelength light (generated by an IS light source and delivered via a fiber optic light pipe built into the catheter) was applied for 200 s to polymerize the monomer. After curing, the catheter was separated from the cured implant. Following implant, the distal femur hole was filled with bone wax. Subcutaneous soft tissues and skin were closed in layers using suture. In local biocompatibility evaluations only, two 1.6 mm diameter titanium K-wires were cut to length, bent slightly to prevent backing out after insertion, and inserted into the right femoral IM canal via the intercondylar drill hole. After wound closure, hind limbs were radiographed, then again prior to euthanasia. Animals were euthanized at 1, 4, 12, 26, or 52 weeks postoperatively.
Femurs and blood samples were collected for analysis. Additional tissues (i.e., ipsilateral popliteal lymph node, ovaries, adrenal gland, spleen, kidney, pancreas, mesentery, heart, and sections of liver, thymus, and lungs) from all systemic biocompatibility group animals were collected and fixed in 10% formalin. Femurs were processed, embedded in Technovit 7200, sectioned, milled, and stained with hematoxylin and eosin (H&E). All tissues were processed using standard techniques and H&E stained.
Bone Healing
After similar fenestration, as described in the biocompatibility evaluations, only the right femoral IM canal was cleaned with a stainless steel spiral brush and saline flushed. A second incision was made over the lateral aspect of the thigh and the femur exposed. An integral drill guide was secured around the femoral diaphysis 40 mm proximal to the distal end of the femur to create three 1.5 mm holes through the anterolateral aspect of the diaphyseal cortex immediately adjacent to one another. These holes were joined by careful removal of the intervening bone with a small osteotome. The resulting defect was $1.5 mm wide Â 4.5 mm long, oriented perpendicular to the long axis of the femur. The IS was implanted into the prepared femoral canal, as described above. Radiographs were collected following wound closure then again prior to euthanasia. Animals were euthanized at 4, 8, 12, or 26 weeks postoperatively.
Femurs and blood samples were collected for analysis. Implanted and naїve femurs were collected and fixed in 10% formalin, then subsequently underwent mCT scanning. Highresolution (30 mm isometric voxel size) volume images were generated of a $30 mm section of the femoral diaphysis centered on the defect site using a micro-computed tomographic imaging system (mCT 40, Scanco Medical AG, Br€ utisellen, Ch). The scanning yielded 1024 Â 1024 grayscale cross-sectional images, which were segmented via simple thresholding (Th ¼ 250) and reconstructed to yield threedimensional volume images. Defect filling was evaluated via inspection of the slice images, as well as the rendered volume images. Femurs were processed, embedded in Technovit 7200, sectioned, milled, and H&E stained.
Device Safety
In Groups 1 and 4, the MC was approached at the hip via the third femur trochanter and a 16 g needle inserted.
Marrow was aspirated with an 18 g Â 3.5 inch spinal needle advanced to the distal femur. Monomer or saline was administered to the MC while withdrawing the spinal needle. The residual hole in the femur was plugged with a small diameter titanium screw. Skin was closed over the wound using liquid bandage.
In Groups 2, 3, and 5 the knee joint was exposed via a parapatellar incision followed by drilling retrograde into the MC at the center of the trochlear groove of the distal femur using a 4.0 mm drill bit. The MC was cleaned with a stainless steel wire brush and flushed/aspirated repeatedly with sterile saline. To simulate a clinical failure, Groups 2 and 3 employed a 4 Â 30 mm fenestrated balloon and catheter advanced into the MC, then 5 ml of monomer was used to expand the balloon. The presence of the fenestrations allowed for leakage of infused liquid monomer into the MC. For Group 2, the delivered 5 ml was immediately withdrawn after administration, the balloon catheter removed from the femur, and the canal repeatedly cleaned with saline flushes, suction, and swabbing with sterile cotton applicators to simulate remediation. For Group 3, following monomer administration, the catheter light source was activated for a total of 400 s in two 200-s curing cycles to polymerize the polymer. The catheter was cut at the point of entry to the femur. For Group 5, no treatment was applied following repeated saline aspiration of the MC. Bone wax was applied in all three groups to close the hole in the femoral trochlea, deep tissues were closed with suture, and the skin incision was sealed with liquid bandage. The hind limbs were wrapped with vet wrap or similar material to limit swelling. Animals were euthanized at 1, 4, 13, 26, or 52 weeks postoperatively.
Femurs and blood samples were collected for analysis. Additional tissues including the lungs, skin/subcutis of the proximal femur access site, stifle joint capsule of the distal femur access site, and tissues with macroscopic findings were collected and placed in 10% NBF. High resolution radiographs (Faxitron X-Ray Corporation 1 ) were obtained of all fixed treated femurs prior to processing/trimming. Femurs were decalcified for histological analysis. Femurs for Groups 1, 2, 4, 5, and 6 and two randomly selected contralateral femurs from each treated group at each time point were paraffin embedded whereas Group 3 was resin embedded; all were H&E stained for qualitative analysis. Sections were taken through each femur, one each at the proximal metaphysis, proximal, mid-and distal diaphysis, and distal metaphysis. Treated femurs were assessed for cortical bone necrosis, cortical vascular necrosis, endosteum loss, endosteum necrosis, inflammation, and new bone formation. Histopathological scoring of parameters reflecting the degree and extent of the host response/repair process to the treatment included but were not limited to inflammation, necrosis, and vascularity. All lung lobes were systematically sampled, processed, and H&E stained and assessed to evaluate the effects of potential embolization of liberated adipose/fat emboli or free, unpolymerized liquid monomer.
Statistical Analysis
Data were reported as means AE standard deviations (SD). Statistical tests of continuous variables were conducted using statistical functions in SigmaPlot 11.0 (Systat Software, Inc., San Jose, CA) and a p-value 0.05 was considered significant. Clinical pathology and body weight changes from baseline were analyzed using a Kruskal-Wallis test (using a Monte Carlo approximation).
Summary of data for histologic parameters are presented as scoring results per recovery interval in a descriptive statistics format (mean and standard deviation scores) to allow qualitative comparisons between groups without statistical analysis. Histopathologic scoring of parameters reflecting the degree and extent of the host response/repair process to the treatment included but were not limited to inflammation, necrosis, and vascularity. For biocompatibility and bone healing evaluations, a severity score was employed based upon the scale of "1" ¼ minimal, "2" ¼ mild, "3" ¼ moderate, and "4" ¼ marked. For safety evaluations, findings were graded as follows 0 ¼ Absent; 1 ¼ Minimal feature/presence in the tissue; 2 ¼ Notable (mild to moderate) feature/presence in the tissue; 3 ¼ Prominent to overwhelming (marked/ severe) feature/presence in the tissue.
RESULTS

Local and Systemic Biocompatibility
Implanted IS and K-wires did not adversely affect hematological, biochemical, or coagulation parameters (Tables 2 and S1 ). Statistical differences were observed between several parameters; however, these were not considered clinically significant as values were within the normal reference ranges for rabbits or were considered due to experimental procedure.
Gross necropsy findings were unremarkable and there were no systemic pathological changes noted on any harvested organ. Radiographic inspection showed K-wires retained in femurs for local biocompatibility and the IS retained in femurs in local and systemic biocompatibility evaluations ( Fig. 1) , as evidenced by the small radiopaque balloon-tip marker centered in the proximal MC, revealing no evidence of device migration.
Histologically at 1 and 4 weeks, K-wires induced minimal increase in remodeling of the inner margin in cortical bone, with minimal to mild inflammation in the medulla, while the IS was tightly apposed to the endosteal surface of cortical bone with minimal to mild mesenchymal reaction between the implant and cortical bone and minimal medullar inflammation. At 12 weeks, both K-wires and IS induced minimal increases in lamellar bone along the junction of cortical bone and bone marrow. In femoral medulla, there was minimal increase in fibrous connective tissue along the bone marrow-device interface for both devices. At 26 weeks, K-wires and IS induced a minimal increase in fibrous connective tissue, forming a narrow, discontinuous band along the device. At 52 weeks, K-wires induced minimal increases in mature lamellar bone, extending from the inner cortical surface around the device and located within the medulla. The IS was tightly apposed to the endosteal surface of cortical bone (Fig. 2) . Neither implant was associated with a significant tissue reaction.
Bone Healing
Implanted IS did not adversely affect hematological, biochemical, or coagulation parameters (Tables 3 and  S2 ). Statistical differences were observed between several parameters; however, these were not considered clinically significant as the values were within the normal reference ranges for the species or were considered due to experimental procedure. Radiographs revealed the IS retained in femurs, as evidenced by the small radiopaque balloon-tip marker centered in the proximal medullary canal (Fig. 3A and B) . Gross necropsy findings were unremarkable. The mid-diaphyseal cortical defect was radiographically visible post-operatively and less visible at subsequent time points, suggesting new bone was filling the defect. Gross inspection of explanted bones revealed that the defects healed rapidly, with new bone filling most of the defects by 4 weeks. By 26 weeks new bone completely filled all defects demonstrating progressive callus remodeling.
Histologic evaluation revealed the IS implant tightly apposed to the endosteal surface of cortical bone. At 26 weeks the fracture site consisted largely of normal remodeled lamellar bone. A slight alteration in the orientation of the lamellar bone, consistent in size, location, and shape of the defect was present, consistent with complete healing of the cortical bone (Fig. 3C-F) .
Consistent with visual assessments, mCT imaging demonstrated most cortical bone defects were completely bridged with woven bone by 4 weeks, which progressively remodeled through week 26 (Fig. 4) . Progressive formation of a periosteal neocortex, and increasing porosity of the original cortical bone, both of which are part of the normal healing and remodeling process was also observed.
Device Safety
There was no radiographic evidence of fractures or calluses for any treated femurs. At 1, 4, 13, 26, and 52 weeks there were variable increases in radiopacity of treated femurs compared to contralateral controls, which was associated with the degree of bone apposition in treated femurs (Supplementary Fig. S1 ). Regardless of treatment, variable necrosis of diaphyseal cortical bone was the major finding. However, for treatments that exposed the MC to liquid monomer and were then immediately remediated via surgical cleaning (Group (2) or monomer polymerization by exposure to the light source (Group (3), the results (i.e., minimal to mild/moderate cortical necrosis) were comparable to sham procedures (Group 5) at all time points (Fig. 5) . Mechanical disruption of vascular endosteum associated with preparation of the MC prior to deployment of an IM fixator was interpreted as the primary cause of cortical necrosis, as previously reported (see discussion), and not transient contact of the MC with monomer.
Unlike Group 2 and 5 treatments, direct monomer injection without remediation (Group 1) resulted in marked cortical necrosis (Supplementary Fig. S2A ) as well as associated vasculature, endosteum, and bone marrow. In addition, unremediated monomer resulted in the presence of minimal to mild intravascular vacuoles in lungs with or without inflammation/infarction ( Supplementary Fig. S2B ) and resulted in increased primary periosteal bone apposition compared to sham saline injection (Group 4). Regardless of treatment group, including shams, areas of necrotic cortical bone persisted through 52 weeks with evidence of varying degrees of active remodeling and/or new bone apposition (Fig. 6) . The relative amount of hematopoietic cellular elements populating the residual medullary adipose tissue increased over time, even adjacent to areas of steatitis in the case of Group 1, and was interpreted to be acceptable and comparable among Groups 2-5 by Day 90, and in Group 1 by Day 180. Although the medullary space was decreased in Group 3 due to the presence of the balloon-implant, marrow tissue was occasionally present and exhibited normal hematopoietic cellularity.
There was no evidence of pulmonary inflammation/ infarction at any time point in Groups 2-5 (except for very minimal evidence in Group 3 at 4 weeks) and only rare, intravascular vacuoles at 1 week with none at any other time point (Table S3) . Additionally, results for clinical failure scenarios (Group 2 and Group 3) were comparable at all time points, providing evidence that mechanical disruption of endosteum was the common denominator across all three treatment groups. Conversely, injection of free monomer into MC without remediation or polymerization (Group 1) resulted in greater incidence of intravascular vacuoles relative to all other groups with minimal to mild vacuole-associated pulmonary inflammation/infarction (Table S3) . However, this effect was mostly limited to 1 week and generally ameliorated by 4 weeks.
Though the exact mechanism observed in bone or lung with free monomer is uncertain, neither the presence of free monomer nor any treatment was found to impede new bone growth (Fig. 7) . Apposition of new bone appeared to be the primary response, thereby providing support to compromised femoral cortices while allowing sufficient time for resorption and remodeling of necrotic cortical bone. 
DISCUSSION
The percutaneous IS conforms to the unique geometry of a MC when filled with a photopolymerizable liquid monomer, then cured with visible light to form a hardened polymeric implant to optimize stable fixation. Clinical studies using the IS have been successful in low load-bearing bones, such as phalanges, metacarpal, radius, ulna, clavicle, fibula, and humerus. 15, 16 Prior preclinical studies in sheep have demonstrated feasibility of the IS for fracture fixation in high loadbearing tibiae. 17 The goals of these studies were to gain a better understanding of the local and systemic biocompatibility, bone healing, and safety characteristics of the monomeric and polymeric material used in the IS in high load-bearing rabbit femurs.
Local biocompatibility evaluations comparing IS to K-wire implants showed no significant tissue or biochemical reaction associated with either implant, while the IS exhibited systemic biocompatibility with no adverse responses biochemically or in abdominal and thoracic organ tissues over the course of a year. Evaluation of bone healing, after creation of middiaphyseal transverse defects, showed the IS was well tolerated in an environment of active bone healing. Since the IS requires IM reaming for implantation, the effects of reaming on bone healing need to be taken into consideration. Reaming of the IM canal is associated with various physiologic effects, such as altering IM pressure and medullary blood flow/supply, fat embolization, autografting, thermal energy generation, release of inflammatory mediators, and in some cases improving fracture healing. [18] [19] [20] [21] Given the abundant new bone formation and almost complete defect filling by 4 weeks post-operatively, the data indicate the IS did not adversely impact bone healing. In addition, there was no evidence of local or systemic devicerelated pathology.
For safety evaluations, the use of intentionally fenestrated balloons to deliver monomer to the MCs of rabbit femurs was deemed a suitable pre-clinical model for the potential clinical scenario of liquid monomer leakage during infusion. The monomer is composed of biocompatible monomers and photo initiators in a proprietary, multifunctional methacrylate that forms a thermoset material. During the curing process this material becomes a cross-linked polymer that permanently retains strength and shape. In the current study, evidence of monomer leakage, immediate remediation procedures (i.e., fenestrated balloon removal with saline lavage/medullary cavity swabbing), or polymerization of monomer resulted in tissue responses comparable to saline lavage/medullary cleaning of sham controls (e.g., minimal to mild/ moderate cortical bone necrosis, etc...). Other than rare, focal areas of minimal inflammation associated with leaked monomer, all other adverse effects appeared related to disruption of MC contents (i.e., bone marrow, endosteum, and endosteal cortical blood supply) secondary to efforts for balloon deployment or post-leakage remediation.
As clinical deployment of the IS requires surgical access to the MC, it was important to understand the impact on cortical bone. Cortical bone necrosis radiating outward from the endosteal surface is a common sequela to surgical manipulation of the MC in long bones (i.e., fracture repair). This pathophysiology has been well discussed in the literature and purported to involve multiple mechanisms including: physical disruption of endosteum and its blood supply 18, 22 ; thermal injury to tissue elements associated with cavity clearing (e.g., irrigation/aspiration, "reaming," etc.) 23 ; exothermic polymerization of surgical resins (e.g., polymethylmethacrylate or PMMA) 18 ; toxicity to tissue elements related to release of bone resin compounds (e.g., PMMA), or occlusion of cortical (i.e., Haversian) vasculature by intravasated marrow or adipose associated with increased IM pressure related to these procedures. [24] [25] [26] Similar to other devices requiring surgical manipulation of the MC, cortical bone necrosis was noted.
Regardless of treatment group, including shams, the relative amount of necrotic cortical bone created at the initial surgical manipulation persisted throughout with evidence of varying degrees of active remodeling and/or new bone apposition. Generally, early periosteal and/or endosteal apposition of new bone appeared to be the primary response, thereby providing support to compromised femoral cortices while allowing sufficient time for necrotic cortical bone resorption/remodeling. However, as cortical necrosis is an expected result following surgical manipulation/preparation of the MC of long bones, the presence of the IS did not appear to preclude the ability of bone to heal as evidenced by periosteal and/or endosteal apposition of new bone and active, progressive remodeling of necrotic cortical bone.
Less clinically relevant was infusion of liquid monomer, without polymerization or remediation procedures. In the clinic, if the liquid monomer does not cure (uncured monomer displays as white and cured polymer displays as black on an MRI scan) after exposure to visible light, then curing can be attempted again or the monomer can be aspirated through the catheter and replaced. Relative to all other groups, monomer solution alone resulted in increased adverse effects observed in bone, such as marked necrosis of cortical bone/vasculature, endosteum, and bone marrow, as well as the presence of intravascular vacuoles in lungs with inflammation and infarction, which was only rarely observed or absent in other groups.
Proliferation of new bone and/or remodeling of preexisting cortical bone are other expected sequelae to surgical manipulation of the MC of long bones when introducing various IM fixation devices. The presence and location of new bone apposition (i.e., periosteal vs. endosteal) and remodeling of existing cortical bone was used to assess the ability of diaphyseal cortical bone to respond to insults (i.e., necrosis) over time. The presence of the IS did not hinder growth of new bone. By 90 days, removal of necrotic cortical bone with new osteonal compact bone, although minimal, was observed regardless of treatment group, including the group receiving monomer without any remediation. Trabecular bone formation was also noted in treatment groups where bone marrow was removed from the MC, although this was somewhat less in the group receiving monomer without remediation. Over time, the MC was associated with a general filling by a mesenchymal/fibrous tissue. This filling was relatively decreased in the monomer without remediation group.
Pulmonary inflammation/infarction is a potential adverse response associated with surgical manipulation of long bones, primarily associated with liberation, and embolization of adipose tissue or liquefied (i.e., "free") fat, secondary to increased IM pressure, during disruption/removal of bone marrow necessary for implantation of IM fixation devices. 24, 27, 28 In addition, rare embolization of liquid phase bone resins (e.g., PMMA) to the lungs have been reported. 29, 30 As such, rabbit lungs were assessed to evaluate the effects of potential embolization of liberated adipose/fat emboli or free, unpolymerized liquid monomer. Injection of free monomer without remediation notably increased the incidence of intravascular vacuoles and areas of pulmonary inflammation and infarction relative to all other groups. The exact nature and pathophysiology of these changes is uncertain since in the absence of physical manipulation of marrow with concomitant increased IM pressure, the liberation of intact adipocytes seems less likely in animals receiving only liquid monomer. Alternatively, vacuoles could represent droplets of embolized liquid monomer or embolized "free" fat, which may have been liberated following the mass necrosis of bone marrow adipocytes or secondary to toxic or lipolytic effects, which have been associated with non-polymerized monomers/polymers. 26, 31 Direct monomer injection was an attempt to examine tissue responses to the monomer alone and as such represents an unlikely clinical situation. The monomer dose delivered to the femoral MC of Group 1 rabbits was four times greater than theoretically possible for a balloon leak of monomer in humans. The effects observed with monomer alone appeared to be consistent with adverse effects associated with polymethyl methacrylate (PMMA), widely used as a bone cement. Though in comparison to PMMA, the exothermic response of the IS material during curing is relatively low with in vitro core temperatures of $62˚C versus $77˚C for PMMA. 25, 32, 33 Regardless, the release of liquid monomer without remediation is an extremely unlikely clinical event and thus would not pose an impediment to the use of the IS.
The monomer used in the IS was generally safe when administered in rabbit femurs. The observed adverse effects were similar to those seen with other current MC devices applied in bone fracture stabilization or bone healing. Overall, when polymerized and hardened within bone IM spaces, this light curable monomer system may provide a biocompatible, safe, and effective method for fracture stabilization and bone healing.
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